Press Releases Access Pharmaceuticals, Inc. OTC Bulletin Board
Equities
ACCP
US00431M3088
End-of-day quote
Other stock markets
|
||
- USD | - |
05-16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
05-15 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |